Mellitus
Ellie McGuire is a Partner of the LS Polaris Innovation Fund. She has held leadership and consulting positions in business development, operations, and strategy in multiple life science companies including Arsia Therapeutics, XTuit Pharmaceuticals, and Lyndra. In addition to serving on the Mellitus Board, Ms. McGuire is a Board observer to Gauss Surgical and Suono Bio. Ms. McGuire is an Expert in Residence for the Harvard Office of Technology Development and is on the Fred Hutch Evergreen Fund Advisory Committee. Prior to co-founding the LS Polaris Innovation Fund, McGuire was the Head of Business Development at Lyndra, where she was also a member of the founding team. She was recently awarded the Up and Coming Woman of the Future Award by WEST.
Ms. McGuire studied neuropsychology at Colby College prior to attending Tuck School of Management Business Bridge Program.
This person is not in the org chart
This person is not in any offices
Mellitus
Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development. Mellitus' lead product candidate is a test for Gestational Diabetes Mellitus (GDM).